Could a common diabetes pill ease anemia in MDS patients?
NCT ID NCT07516847
First seen Apr 28, 2026 · Last updated May 21, 2026 · Updated 6 times
Summary
This study tests whether dapagliflozin, a drug used for diabetes, can improve anemia in people with lower-risk myelodysplastic syndromes (MDS). Anemia causes fatigue and often requires blood transfusions. About 37 adults will take the pill daily for 24 weeks to see if their hemoglobin levels rise and reduce the need for transfusions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.